Stronger cholesterol medicine helps heart patients more

Original Title

Effect of More Intensive LDL-C-Lowering Therapy on Long-term Cardiovascular Outcomes in Early-Phase Acute Coronary Syndrome: A Systematic Review and Meta-analysis.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

When people with a recent heart problem take stronger cholesterol-lowering medicine early, they have fewer heart attacks and strokes later.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

The benefit of intensive therapy was much larger in patients with high baseline LDL-C (>130 mg/dL) than in those with lower levels, despite all receiving the same relative treatment increase.

It was previously unclear whether patients already on statins with lower LDL-C would benefit from further intensification. This shows the biggest gains are in those starting high.

Practical Takeaways

If you’ve had a heart attack and your LDL-C is above 130 mg/dL, talk to your doctor about whether adding a second cholesterol-lowering drug (like ezetimibe) could help.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.